IMMX icon

Immix Biopharma

12 hedge funds and large institutions have $730K invested in Immix Biopharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 9 closing their positions.

Holders
12
Holders Change
-6
Holders Change %
-33.33%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$192K 105,357
UB
2
UMB Bank
Missouri
$181K 99,300 +99,300 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$145K 79,722 +3,185 +4%
State Street
4
State Street
Massachusetts
$78.2K 42,960
MAWA
5
Moss Adams Wealth Advisors
Washington
$36.5K 20,078 +78 +0.4%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$32.3K 17,723 +17,723 New
ICG
7
InterOcean Capital Group
Tennessee
$28.9K 15,900
GSC
8
Ground Swell Capital
South Carolina
$19.5K 10,692 +10,692 New
TRCT
9
Tower Research Capital (TRC)
New York
$12K 6,375 +4,019 +171%
UBS Group
10
UBS Group
Switzerland
$4.19K 2,301 -2,386 -51%
Osaic Holdings
11
Osaic Holdings
Arizona
$637 350
Wells Fargo
12
Wells Fargo
California
$69 38 +1 +3%
M
13
Murchinson
Ontario, Canada
-67,200 Closed
BFM
14
Boothbay Fund Management
New York
-33,600 Closed
LCM
15
Lynwood Capital Management
Ontario, Canada
-25,000 Closed
Northern Trust
16
Northern Trust
Illinois
-19,151 Closed
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
-15,000 Closed
TSS
18
Two Sigma Securities
New York
-12,597 Closed
Bank of America
19
Bank of America
North Carolina
-10 Closed
Fidelity Investments
20
Fidelity Investments
Massachusetts
-7 Closed
Morgan Stanley
21
Morgan Stanley
New York
-1 Closed
CFGS
22
Concourse Financial Group Securities
Alabama